Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2023 Earnings Call Transcript

George Sellers: And then maybe for the 10 new technologies that you’ve talked about launching over the next 12 months, could you give some additional color on how many of those are maybe new devices that are attacking new foot-and-ankle deformities versus improving on and updating some of the existing devices that you currently have in your portfolio?

John Treace: Yes, George, I would say the majority of them are new significant impact products, significant innovations. RedPoint technology, that’s 1 of them. Something that’s coming beyond that in the back half of the year that Mark alluded to will, we believe, help us expand and increase penetration into the bunion market. That’s a major significant platform. And then we have a handful between call it now and the first half of the year that we’ll be introducing as well.

Julie Dewey: I think that’s it for today, everybody. Thank you for joining us. We appreciate your time and interest. If you have more questions, please reach out and we’ll look forward to talking to you next quarter. This concludes our call.